MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury (Q36300048)

13 August 2017

1 reference

title

MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury (English)

1 reference

13 August 2017

Paul W Armstrong

3

0 references

Robert A Harrington

8

object named as

Robert A Harrington

1 reference

13 August 2017

1

David E Kandzari

1 reference

13 August 2017

Jean-Pierre Dery

2

1 reference

13 August 2017

Deborah A Douglas

4

1 reference

13 August 2017

Marjorie E Zettler

5

1 reference

13 August 2017

G Karl-Gunnar Hidinger

6

1 reference

13 August 2017

Albert D Friesen

7

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Expert Opinion on Investigational Drugs

13 August 2017

published in

1 reference

13 August 2017

volume

14

1 reference

13 August 2017

issue

11

1 reference

13 August 2017

page(s)

1435-1442

1 reference

Myocardial reperfusion: a double-edged sword?

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Does reperfusion injury exist in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

The global burden of disease, 1990–2020

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Pyridoxal phosphate breakdown by an alkaline-phosphatase preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Pyridoxal phosphate enzymes: mechanistic, structural, and evolutionary considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Inactivation of rat liver RNA polymerases I and II and yeast RNA polymerase I by pyridoxal 5'-phosphate. Evidence for the participation of lysyl residues at the active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Observations on the pyridoxal 5'-phosphate inhibition of DNA polymerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Time to therapy and salvage in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Leukocyte adhesion to the coronary microvasculature during ischemia and reperfusion in an in vivo canine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Mechanism of myocardial "stunning".

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Release of adenosine triphosphate from isolated adult heart cells in response to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

In vitro studies of release of adenine nucleotides and adenosine from rat vascular endothelium in response to alpha 1-adrenoceptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

P2-purinergic receptors: subtype-associated signaling responses and structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Role of MC-1 alone and in combination with tissue plasminogen activator in focal ischemic brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Prognostic implication of creatine kinase elevation following elective coronary artery interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Cytolytic P2X purinoceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1435

10.1517/13543784.14.11.1435

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference